Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research offers new hope for antibiotic resistance
Scientists say their findings could reverse the rising tide of antibiotic resistance.
Findings could ‘turn back the rising tide' of AMR

What makes some bacteria resistant to the most commonly prescribed antibiotics, and how this can be reversed, has been identified by scientists.

In a study, a team of researchers defined the relative importance of two mechanisms associated with β-lactams - a commonly prescribed group of antibiotics that includes penicillins, cephalosporins and carbapenems.

They found that, in one mechanism, bacteria restrict the entry of antibiotics into the cell. In the other, bacteria produce an enzyme, which destroys any antibiotic that gets into the cell. The latter was identified as the as the more important of the two mechanisms.

Scientists say their findings suggest that if chemicals could be developed to inhibit β-lactamase enzymes, a significant proportion of antibiotic resistance could be successfully reversed.

Building on these findings, a team from the University of Bristol studied the effectiveness of two types of β-lactamase enzyme inhibitor in a bacterium known to be highly resistant to common antibiotics.

They found both inhibitors failed consistently to protect the β-lactam antibiotic (ceftazidime) from attack by the β-lactamase enzyme. But when coupled with a different β-lactam antibiotic (aztreonam), the inhibitors worked very well - killing some of the most resistant bacteria the clinic had ever seen.

“Our bacteriology research has further demonstrated that β-lactamases are the real “Achilles heel” of antibiotic resistance in bacteria that kill thousands of people in the UK every year,” commented senior author Dr Matthew Alison from the University of Bristol.

“This is an exciting time for researchers studying β-lactamase inhibitors. At the risk of sounding like King Canute, it is the first time for a decade that there is some genuine positivity about our ability to turn back the rising tide of β-lactam antibiotic resistance.”

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Government releases latest bluetongue statistics

APHA has confirmed the number of bluetongue cases that have been logged in the UK since 1 July 2026.

The total number of BTV-3 cases, as of 6 August, is 187. This includes 183 cases in England and four cases in Wales.

There have been no recorded cases in Scotland and Northern Ireland.

The location of premises in Great Britain where at least one animal has tested positive by PCR for BTV-3, BTV-8 or BTV-12 is available on the bluetongue case map. All livestock keepers in Great Britain are urged to familiarise themselves with nation-specific bluetongue control policies.

Bluetongue virus is a notifiable disease. It is a legal requirement that any suspicions, even if livestock has been vaccinated, are reported immediately.